TITLE

Akzo plays down Organon sale

AUTHOR(S)
Ovrebekk, Hilde; Davis, Nigel; Chang, Joseph
PUB. DATE
January 2007
SOURCE
ICIS Chemical Business Americas;1/8/2007, Vol. 271 Issue 1, p6
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that Akzo Nobel denied its plan to sell its Organon drugs business to private equity instead of going ahead with its initial public offering (IPO) plan. The sale of Organon human health care and the Intervet animal health businesses to private investors continue to eye a possible approach from the Dutch chemicals firm for ICI. An Akzo Nobel official said that the company's preferred option is still IPO.
ACCESSION #
23796824

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics